Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT

Condition:   Head and Neck Cancer
Intervention:   Drug: Megestrol acetate (MA) 400 mg/day
Sponsors:   TTY Biopharm;   Chang Gung Memorial Hospital
Recruiting - verified July 2016

http://ift.tt/2ghfcG9